Elaidylphosphocholine

Elaidylphosphocholine

SCHEMBL18952927

CCCCCCCC/C=C/CCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.82
AKT1 P31749 2/20 0.82
ESR1 P03372 1/20 0.82
ADORA3 P0DMS8 1/20 0.82
CDC25A P30304 1/20 0.82
AGTR1 P30556 1/20 0.82
ADRA1A P35348 1/20 0.82
KCNH2 Q12809 1/20 0.82
MEN1 O00255 2/20 0.63
KMT2A Q03164 2/20 0.63
S1PR1 P21453 1/20 0.63
ALDH1A1 P00352 2/20 0.60
PRKD3 O94806 1/20 0.60
PRKCG P05129 1/20 0.60
PRKCB P05771 1/20 0.60
PRKCA P17252 1/20 0.60
PRKCH P24723 1/20 0.60
PRKCI P41743 1/20 0.60
PRKCE Q02156 1/20 0.60
PRKCQ Q04759 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Elaidylphosphocholine SCHEMBL10415339 1.00 LMNA (0.82) LMNAAKT1ESR1ADORA3CDC25A
Oleylphosphocholine SCHEMBL3332097 1.00 LMNA (0.82) LMNAAKT1ESR1ADORA3CDC25A
Erufosine SCHEMBL4064798 1.00 LMNA (0.82) LMNAAKT1ESR1ADORA3CDC25A
Erufosine SCHEMBL18343547 1.00 LMNA (0.82) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL23016704 1.00 LMNA (0.82) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL23016878 1.00 LMNA (0.82) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL21094307 0.94 LMNA (0.72) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL10937575 0.92 LMNA (0.69) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL10934199 0.92 LMNA (0.69) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL30008220 0.92 LMNA (0.69) LMNAAKT1ESR1ADORA3CDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4366837-A2 COMPOSITSONS AND METHODS FOR DECREASING PIGMENTATION The General Hospital Corporation (US) 2024-05-15 EP claimed
WO-2023283554-A2 COMPOSITSONS AND METHODS FOR DECREASING PIGMENTATION THE GENERAL HOSPITAL CORPORATION (US) 2023-01-12 WO claimed
EP-3386498-A1 METHOD FOR MODULATING AUTOPHAGY AND APPLICATIONS THEREOF Jawaharlal Nehru Centre For Advanced Scientific Research (IN) 2018-10-17 EP claimed
WO-2017098467-A1 METHOD FOR MODULATING AUTOPHAGY AND APPLICATIONS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2017-06-15 WO claimed
US-20240307283-A1 COMPOSITIONS AND METHODS FOR DECREASING PIGMENTATION THE GENERAL HOSPITAL CORPORATION 2024-09-19 US disclosed
EP-4366837-A2 COMPOSITSONS AND METHODS FOR DECREASING PIGMENTATION The General Hospital Corporation (US) 2024-05-15 EP disclosed
WO-2023283554-A2 COMPOSITSONS AND METHODS FOR DECREASING PIGMENTATION THE GENERAL HOSPITAL CORPORATION (US) 2023-01-12 WO disclosed
US-20180369186-A1 METHOD FOR MODULATING AUTOPHAGY AND APPLICATIONS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2018-12-27 US disclosed
EP-3386498-A1 METHOD FOR MODULATING AUTOPHAGY AND APPLICATIONS THEREOF Jawaharlal Nehru Centre For Advanced Scientific Research (IN) 2018-10-17 EP disclosed
WO-2017098467-A1 METHOD FOR MODULATING AUTOPHAGY AND APPLICATIONS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2017-06-15 WO disclosed